Selection from HEOR Bibliography

IMS logo
Search criteria
Condition: Rheumatology
 
Budget IMPACT Analysis of a Reduced Maintenance Dose of Certolizumab Pegol in Patients with Axial Spondyloarthritis in the United Kingdom
Authors: Kiri S, Arteaga Duarte C, Lamotte M, Gerlier L
Affiliations: IQVIA HEOR Zaventem
Publications: 
ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 107821
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2020 English , clinical setting: Secondary care, Cost effectiveness
 
 
Cost-Effectiveness Analysis of Certolizumab Pegol Versus Secukinumab and Ixekizumab in Non-Radiographic Axial Spondyloarthritis in the U.S
Authors: Kiri S, Arteaga Duarte Ca, Lee E, Low R, Tsakeu E, Lamotte M, Gerlier L.
Affiliations: IQVIA HEOR Zaventem
Publications: 
AMCP Nexus 2020 Virtual October 19.
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2020 English , clinical setting: Secondary care, Cost effectiveness
 
 
Reduction in the Utilization of Prednisone or Methotrexate in Canadian Claims Data Following Initiation of Etanercept in Pediatric Patients with Juvenile Idiopathic Arthritis
Authors: Majed M M Khraishi1, Brad Millson2, John Woolcott3, Lisa Marshall4 and Heather Jones4
Affiliations: 1Memorial University of Newfoundland, St John's, NF, Canada, 2IQVIA, Kanata, ON, Canada, 3Global Outcomes & Evidence, Pfizer, Collegeville, PA, 4Pfizer, Collegeville, PA
Publications: 
Annals of the Rheumatic Diseases 2018;77:494.
Document Types: , Article
Countries: , Canada
Abstract: https://acrabstracts.org/abstract/reduction-in-the-utilization-of-prednisone-and-or-methotrexate-following-the-initiation-of-etanercept-in-pediatric-patients/
Condition Year Language Analysis type
, Pediatrics, Rheumatology 2019 English , Longitudinal study, Retrospective database analysis
 
 
Real-world utilization of methotrexate or prednisone co-therapy with etanercept among Canadian patients with rheumatoid arthritis: a retrospective cohort study
Authors: Majed Khraishi, Jelena Ivanovic, Yvonne Zhang, Brad Millson, Marie-Josee Brabant, John Woolcott, Heather Jones & Cinzia Curiale
Affiliations: 
Publications: 
Journal of Current Medical Research and Opinion, Accepted author version posted online: 25 Jun 2019, Published online: 10 Jul 2019
Document Types: , Article
Countries: , Canada
Abstract: ?https://doi.org/10.1080/03007995.2019.1636543
Condition Year Language Analysis type
, Rheumatology 2019 English , Retrospective cohort analysis
 
 
Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain.
Authors: Schlueter M, Finn E, Díaz S, Dilla T, Inciarte-Mundo J, Fakhouri W.
Affiliations: IQVIA, Real World Evidence, London N1 9JY, UK. Lilly Spain, Health Outcomes & RWE, Alcobendas 28108, Spain. Lilly Spain, Medical, Alcobendas 28108, Spain. Lilly, Global Patient Reported Outcomes and Real World Evidence (GPORWE) International, Windlesham, Surrey GU20 6PH, UK.
Publications: 
Clinicoecon Outcomes Res. 2019 Jun 6;11:395-403
Document Types: , Article
Countries: , Spain
Abstract: https://www.dovepress.com/cost-effectiveness-analysis-of-baricitinib-versus-adalimumab-for-the-t-peer-reviewed-fulltext-article-CEOR
Condition Year Language Analysis type
, Rheumatology 2019 English , Retrospective cohort analysis
 
 
Biological Treatment Patterns with Inflammatory Joint Diseases. Retrospective Study with 4 Years Follow-up
Authors: Cañete JD1, Naranjo A2, Calvo J3, Ordás C4, Aragón B5, Nocea G5, Roset M6, Fernández-Nebro A7
Affiliations: 1 Servicio de Reumatología, Hospital Clínic e IDIBAPS, Barcelona, Spain 2 Departamento de Reumatología, Hospital Dr. Negrín, Universidad de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain 3 Departamento de Reumatología, Hospital General Universitario de Valencia, Valencia, Spain 4 Departamento de Reumatología, Hospital de Cabueñes, Gijón, Spain 5 Departamento de Health Economics and Outcomes Research, MSD, Madrid, Spain 6 IQVIA, Barcelona, Spain 7 Departamento de Reumatología, Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain
Publications: 
Reumatol Clin. 2019 Jan 28. pii: S1699-258X(18)30259-6
Document Types: , Article
Countries: , Spain
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30704919
Condition Year Language Analysis type
, Rheumatology 2019 Spanish , Population Based Study, Survey research
 
 
Evaluation of the Effectiveness of Risk Minimisation Measures Targeting Physicians on Prescribing Practices of Thiocolchicoside Containing Medicinal Products for Systemic Use
Authors: Jouaville LS, Ehrhardt C, Kürzinger ML, de Voogd H, Toussi M
Affiliations: IQVIA
Publications: 
Epidemiology (Sunnyvale) 9: 372. DOI: 10.4172/2161-1165.1000372
Document Types: , Article
Countries: , France, Greece, Italy, Portugal
Abstract: https://www.omicsonline.org/open-access/evaluation-of-the-effectiveness-of-risk-minimisation-measures-targeting-physicians-on-prescribing-practices-of-thiocolchicoside-co-2161-1165-1000372-108159.html
Condition Year Language Analysis type
, Musculoskeletal disease, Rheumatology, Risk Management & REMS 2019 English , Survey research
 
 
Two-year adherence and costs for biologic therapy for rheumatoid arthritis
Authors: Stolshek BS, Wade S, Mutebi A, De AP, Wade RL, Yeaw J
Affiliations: Amgen, IQVIA
Publications: 
Am J Manag Care
Document Types: , Article
Countries: , USA
Abstract: https://www.ajmc.com/journals/issue/2018/2018-vol24-sp8/twoyear-adherence-and-costs-for-biologic-therapy-for-rheumatoid-arthritis?p=1
Condition Year Language Analysis type
, Rheumatology 2018 English , Cost analysis, Retrospective cohort analysis
 
 
Assessing Treatment Tolerability for Rheumatoid Arthritis. Validation and Practical Applications of the ‘TOL-AR-18 Questionnaire
Authors: Corominas H, Espadaler L, Gómez A, Ros I, Urruticoechea A, Sarmiento M, Sanmartí R
Affiliations: Corominas H.: Rheumatology and Autoimmune diseases Division, Hospital Universitari de Sant Pau & Hospital Dos de Maig, Barcelona, Spain Sarmiento M: Real-World Evidence Solutions, IMS Health, Spain
Publications: 
Reumatología Clínica 2018; Sep 5. [Epub ahead of print]
Document Types: , Article
Countries: , Spain
Abstract: http://www.reumatologiaclinica.org/en/assessing-treatment-tolerability-for-rheumatoid/avance-resumen/S1699258X18301232/
Condition Year Language Analysis type
, Health status & patient reported outcomes, Rheumatology 2018 English , Clinical setting: hospital, Observational study
 
 
Canadian Study of Adherence Outcomes in HUMIRA® (Adalimumab) Patients – Three-Year Results from the COMPANION Study in Rheumatology Patients
Authors: Bessette L1, Millson B2, Sung M2, Gaetano T3, Latour M3, Laliberté MC3
Affiliations: 1 Department of Medicine, Laval University, Quebec City, Quebec, Canada 2 IMS Brogan, Kirkland, Quebec, Canada; 3AbbVie Corporation, St. Laurent, Quebec, Canada
Publications: 
Canadian Rheumatology Association 2017 Scientific Meeting, February 8-11, Ottawa, Canada
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/abbvie-cra-2017.pdf
Condition Year Language Analysis type
, Rheumatology 2017 English , Database Study
 
 
Regional policies impact on biosimilar adoption for autoimmune diseases in Italy
Authors: Tucci C1, Rova A1, Mantuano M1, Tettamanti A1
Affiliations: QuintilesIMS, Milan, Italy
Publications: 
ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland
Document Types: , Poster
Countries: , Italy
Condition Year Language Analysis type
, Dermatology, Gastrointestinal disorders, Health policy, Rheumatology 2017 English , Literature Review
 
 
Market share and switching dynamics between Etanercept and its biosimilar product in Sweden and Germany: a real-world preliminary analysis.
Authors: Alten R1, Neregård P2, Jones HE3, Meng T4, Curiale C5, Singh E6, Lucchese L7, Gossen N8, Bergman GJ9, Miglio C7
Affiliations: 1 Shlosspark-Klinik Teaching Hospital of the Charité, Berlin, Germany 2 Pfizer, Sollentuna, Sweden 3 Pfizer inc., Collegeville, PA, USA 4 Pfizer Pharma GmbH, Berlin, Germany 5 Pfizer, Rome, Italy 6 Pfizer Inc., Collegeville, PA, USA 7 QuintilesIMS, London, UK 8 QuintilesIMS, Frankfurt, Germany 9 QuintilesIMS, Solna, Sweden
Publications: 
ISPOR 20th Annual European Congress
Document Types: 
Countries: , Germany, Nordic, Sweden
Abstract: https://www.ispor.org/Event/ProgramList/2017Glasgow?type=Poster&sess=II&acode=PSY
Condition Year Language Analysis type
, Immunology and Vaccination, Patient Registries & Real-World Study Methods, Rheumatology 2017 English , Retrospective database analysis
 
 
Depression risk in patients with rheumatoid arthritis in the United Kingdom
Authors: Jacob L,Rockel T, Kostev K
Affiliations: 
Publications: 
Rheumatol Ther. 2017 Mar 20. doi: 10.1007/s40744-017-0058-2. [Epub ahead of print]
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Mental health, Rheumatology 2017 English
 
 
COMMONALITIES AND DIFFERENCES IN DATA COLLECTION ACROSS EUROPEAN SPONDYLOARTHRITIS REGISTRIES
Authors: M. L. Hetland* 1, M. Østergaard1, J. Askling2, C. Gabay3, D. Nordstrom4, O. FitzGerald5, M. Hernández Miguel6, M. Santos7 , Z. Rotar8, H. Mann9, F. Iannone10, M. J. Nissen3, E. Hauge1, J. Gomez-Reino11, F. Díaz-González12, M. Tomsic8, K. Pavelka9, F. O'Shea5, C. Sullivan5, M. van de Sande13, I. E. van der Horst-Bruinsma13, G. J. Macfarlane14, G. T. Jones14, B. Gudbjørnsson15, T. K. Kvien16 on behalf of EuroSpA Study Group
Affiliations: 1DANBIO, Glostrup, Denmark, 2ARTIS, Stockholm, Sweden, 3SCQM, Geneva, Switzerland, 4ROB-FIN, Helsinki, Finland, 5ASRI, Dublin, Ireland, 6BIOBADASER, Barcelona, Spain, 7reuma.pt, Almada, Portugal, 8biorx.si, Ljubljana, Slovenia, 9ATTRA, Prague, Czech Republic, 10GISEA, Bari, Italy, 11BIOBADASER, Santiago, 12BIOBADASER, Santa Cruz de Tenerife, Spain, 13ARC, Amsterdam, Netherlands, 14BSRBR-AS, Aberdeen, United Kingdom, 15ICEBIO, Reykjavik, Iceland, 16NORDMARD, Oslo, Norway
Publications: 
EULAR, Madrid, 2017
Document Types: , Abstract
Countries: , Czech, Denmark, Finland, Ireland, Italy, Norway, Slovenia, Spain, Sweden, Switzerland
Abstract: http://ard.bmj.com/content/76/Suppl_2/656.3
Condition Year Language Analysis type
, Rheumatology 2017 English , Epidemiological study
 
 
Cross-cultural validation of Lupus Impact Tracker in five European clinical practice settings
Authors: Schneider M, Mosca M, Pego-Reigosa JM, Gunnarsson I, Maurel F, Garofano A, Perna A, Porcasi R, Devilliers H
Affiliations: Policlinic of Rheumatology, Hiller Research Unit, Heinrich-Heine University, Düsseldorf, Germany. Department of Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy. Department of Rheumatology, Complexo Hospitalario Universitario de Vigo, Ourense y Pontevedra, Spain. Department of Medicine, Unit of Rheumatology, Karolinska Institutet, Solna, Sweden. HEOR, Real-World Evidence Solutions (RWES) unit, IMS Health, Paris-La Défense, France. Global Specialty Pharma Franchise, GlaxoSmithKline; Services Unlimited, Brentford, UK. Immunology Medical Department, GlaxoSmithKline spa, Verona, Italy. Department of Internal Medicine and Systemic Diseases, University Hospital of Dijon, 5bis INSERM U866 5ter INSERM CIC-EC 1432, Dijon, France.
Publications: 
Rheumatology (Oxford). 2017 May 1;56(5):818-828
Document Types: , Article
Countries: , France, Germany, Italy, Spain, Sweden
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28204765
Condition Year Language Analysis type
, Immunology and Vaccination, Rheumatology 2017 English , Retrospective Field Study
 
 
Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Authors: Lyu R1, Govoni M2, Ding Q1, Black CM3, Kachroo S4, Fan T1, Ogbonnaya A5, Donga P5, Hill J5, Makin C5.
Affiliations: 1Merck Co., Inc, Whitehouse Station, NJ, USA. 2MSD Italy, Rome, Italy. 3Merck Co., Inc, 126 E. Lincoln Avenue, Mail code: RY32-211, Rahway, NJ, 07065, USA. 4Merck Co., Inc, 126 E. Lincoln Avenue, Mail code: RY32-211, Rahway, NJ, 07065, USA. sumesh.kachroo@merck.com. 5IMS Health, Alexandria, VA, USA.
Publications: 
Rheumatol Int. 2016 Jan;36(1):143-53.
Document Types: , Article
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26314368
Condition Year Language Analysis type
, Rheumatology 2016 English , Retrospective database analysis
 
 
Canadian Study of Outcomes in HUMIRA® (Adalimumab) Patients with Support for Adherence - Results from the COMPANION Study
Authors: Gerega S1, Millson B1, Bessette L2, Marshall JK3, Lebovic G4,5, Sung M1, Oraichi D1, Gaetano T6, Gazel S6, Latour M6, Laliberté MC6
Affiliations: 1 IMS Brogan, Kirkland, Quebec, Canada 2 Department of Medicine, Laval University, Quebec City, Quebec, Canada 3 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton, Ontario, Canada 4 Applied Health Research Centre, St. Michael’s Hospital, Toronto, Ontario, Canada 5 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 6 AbbVie Corporation, St. Laurent, Quebec, Canada
Publications: 
American College of Rheumatology 2016 Annual Meeting, November 11-16, Washington DC, USA
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/abbvie-acr-poster-2016.pdf
Condition Year Language Analysis type
, Medication compliance, Rheumatology 2016 English , Database Study
 
 
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis.
Authors: Morlock R1, Chevalier P2, Horne L3, Nuevo J4, Storgard C1, Aiyer L1, Hines DM5, Ansolabehere X6, Nyberg F7,8
Affiliations: 1 Ardea Biosciences, San Diego, CA, USA 2 IMS Health HEOR, Zaventem, Belgium 3 AstraZeneca, Wilmington, DE, USA 4 AstraZeneca, Madrid, Spain 5 IMS Health HEOR, Fairfax, VA, USA, 6 IMS Health HEOR, Paris, France, 7 AstraZeneca, Mölndal, Sweden 8 University of Gothenburg, Gothenburg, Sweden
Publications: 
Rheumatol Ther., 2016, 3(1): 53-75
Document Types: , Article
Countries: , France, Germany, UK, USA
Condition Year Language Analysis type
, Rheumatology 2016 English
 
 
Validity of ankylosing spondylitis diagnoses in The Health Improvement Network
Authors: Dubreuil M, Peloquin C, Zhang Y, Choi HK, Inman RD, Neogi T
Affiliations: Boston University School of Medicine, Section of Rheumatology; VA Boston Healthcare System; Massachusetts General Hospital, Section of Rheumatology; University of Toronto, Toronto Western Hospital
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Database Validity and methodology, Drug safety, Rheumatology 2016 English , Retrospective database analysis
 
 
Use of non-steroidal anti-inflammatory drugs correlates with the risk of venous thromboembolism in knee osteoarthritis patients: a UK population-based case-control study
Authors: Lee T, Lu N, Felson DT, Choi HK, Dalal DS, Zhang Y, Dubreuil M
Affiliations: Clinical Epidemiology Research and Training Unit, Boston University School of Medicine; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital; Section of Rheumatology, Boston University School of Medicine
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Rheumatology 2016 English , Retrospective database analysis
 
 
Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study
Authors: Lu N, Dubreuil M, Zhang Y, Neogi T, Rai SK, Ascherio A, Hernán MA, Choi HK
Affiliations: Clinical Epidemiology Unit, Boston University School of Medicine; Arthritis Research Centre of Canada, University of British Columbia; Department of Epidemiology, Harvard School of Public Health; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Mental health, Miscellaneous, Rheumatology 2016 English , Retrospective database analysis
 
 
Improved survival in rheumatoid arthritis: a general population-based cohort study
Authors: Zhang Y, Lu N, Peloquin C, Dubreuil M, Neogi T, Aviña-Zubieta JA, Rai SK, Choi HK
Affiliations: Clinical Epidemiology Research and Training Unit, Boston University School of Medicine; Arthritis Research Canada, University of British Columbia, Vancouver; Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Rheumatology 2016 English , Retrospective database analysis
 
 
Second-line therapy with biological drugs in rheumatoid arthritis patients in German rheumatologist practices: a retrospective database analysis
Authors: Gossen N, Jacob L, Kostev K
Affiliations: 
Publications: 
Rheumatol Int. 2016 Aug;36(8):1113-8
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Musculoskeletal disease, Rheumatology 2016 English , Retrospective database analysis
 
 
Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Authors: Lyu R, Govoni M, Ding Q, Black CM, Kachroo S, Fan T, Ogbonnaya A, Donga P, Hill J, Makin C.
Affiliations: 
Publications: 
Rheumatol Int. 2016 Jan;36(1):143-53. doi: 10.1007/s00296-015-3348-4.
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Rheumatology 2016 English
 
 
Drug utilization in rheumatoid arthritis from a large japanese hospital administrative database
Authors: Crawford B, Kim J
Affiliations: IMS Health, Real-world Evidence Solutions, Tokyo, Japan
Publications: 
pharmacoepidemiology and drug safety 2015; 24: 142
Document Types: , Abstract
Countries: , Japan
Condition Year Language Analysis type
, Rheumatology 2015 English , Retrospective database analysis
 
 
Septic arthritis in gout patients: a population-based cohort study
Authors: Lim SY, Lu N & Choi HK
Affiliations: Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School
Publications: 
Rheumatology (Oxford)
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Rheumatology 2015 English , Retrospective database analysis
 
 
Clinical profile and direct medical cost of care of adults presenting with systemic lupus erythematosus in Italy.
Authors: Doria A1, Iaccarino L1, La Montagna G2, Mathieu A3, Piga M3, Galeazzi M4, Iuliano A4, Maurel FB5, Garofano AM5, Perna AG6, Porcasi RE7.
Affiliations: 1Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy. 2Rheumatology Unit, Second University of Napoli, Napoli, Italy. 3Division of Rheumatology, Department of Medical Sciences, University of Cagliari, Cagliari, Italy. 4Department of Rheumatology, Ospedale Santa Maria alle Scotte, University of Siena, Siena, Italy. 5HEOR, Real-World Evidence Solutions (RWES) unit, IMS Health, Paris-La Défense, France. 6Immuno-Inflammation & Infectious Diseases (II-ID) Global Franchise, GlaxoSmithKline, London, UK. 7Speciality Care Medical Department, GlaxoSmithKline, Verona, Italy
Publications: 
Clinical and experimental rheumatology (2015)
Document Types: , Article
Countries: , Italy
Condition Year Language Analysis type
, Rheumatology 2015 English , Cost analysis, Observational study, Real World Data
 
 
REDUCTION IN C-REACTIVE PROTEIN WITH BIOLOGIC DRUGS IN RHEUMATOID ARTHRITIS AND SPONDYLITIS PATIENTS IN GERMAN RHEUMATOLOGIST PRACTICES
Authors: Gossen N, Kostev K
Affiliations: IMS Health, Frankfurt am Main, Germany
Publications: 
ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , Germany
Condition Year Language Analysis type
, Drug safety, Rheumatology 2015 English
 
 
Characteristics, Referral and Treatment Patterns of Patients Diagnosed with Psoriatic Arthritis ? A Retrospective Cohort Study Based in Sweden
Authors: J. Rockberg1, M. Mittal2, A. Joshi2, Y. Bao2, J. Anderson3, R. Linder1, J. Stålhammar4, U. Lindqvist5
Affiliations: 1Real World Evidence Solutions & HEOR, Pygargus AB/IMS Health, Stockholm, Sweden 2Health Economics and Outcomes Research (HEOR) 3Immunology Clinical Development, AbbVie Inc, Chicago, United States 4Department of Public health and Caring Sciences; Family Medicine and Preventive Medicine 5Department of Medical Sciences, Uppsala University, Uppsala, Sweden
Publications: 
Ann Rheum Dis
Document Types: , Oral presentation
Countries: , Nordic, Sweden
Abstract: http://ard.bmj.com/content/74/Suppl_2/64.2
Condition Year Language Analysis type
, Rheumatology 2015 English , Real World Evidence
 
 
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study.
Authors: Emery P1, Gottenberg JE2, Rubbert-Roth A3, Sarzi-Puttini P4, Choquette D5, Taboada VM6, Barile-Fabris L7, Moots RJ8, Ostor A9, Andrianakos A10, Gemmen E11, Mpofu C12, Chung C13, Gylvin LH12, Finckh A14.
Affiliations: 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK. 2Department of Rheumatology, CHU Strasbourg, Strasbourg, France. 3University of Cologne, Cologne, Germany. 4L Sacco University Hospital, Milan, Italy. 5University of Montreal, Montreal, Canada. 6Facultad de Medicina, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain. 7Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México City, Mexico. 8Department of Rheumatology, University of Liverpool, Liverpool, UK. 9Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. 10Hellenic Foundation for Rheumatological Research, Athens, Greece. 11Quintiles, Rockville, Maryland, USA. 12F Hoffmann-La Roche Ltd, Basel, Switzerland. 13Genentech Inc, San Francisco, California, USA. 14University Hospital of Geneva, Geneva, Switzerland.
Publications: 
Ann Rheum Dis. 2015 Jun;74(6):979-84
Document Types: , Article
Countries: , Canada, Colombia, France, Germany, Greece, Italy, Mexico, Norway, Portugal, Spain, UK
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431330/
Condition Year Language Analysis type
, Comparative Effectiveness & Health Technology Assessment, Rheumatology 2015 English , Clinical setting: hospital, clinical setting: Secondary care, Prospective study, RWLPR (Real-World Late Phase Research-quintiles
 
 
Identifying psoriasis and psoriatic arthritis patients in retrospective databases when diagnosis code is not available: A validation study comparing medication/prescriber visit based algorithms to diagnosis codes
Authors: Dobson-Belaire W1, Borrelli R1, Goodfield J1, Liu FF2, Khan ZM3
Affiliations: 1IMS Brogan, Mississauga, ON, Canada, 2Celgene Inc., Mississauga, ON, Canada, 3Celgene Corporation, Summit, NJ, USA
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Methodology, Rheumatology 2014 English , Retrospective database analysis
 
 
Concomitant use of non-steroidal anti-inflammatory drugs (NSAIDS) and proton pump inhibitors (PPIS) in newly diagnosed patients with osteoarthritis (OA), rheumatoid arthritis (RA) or ankylosing spondylitis (AS)
Authors: Dziarmaga A1, Reidel K2, White R1, Tarride J1, Corner N2
Affiliations: 1AstraZeneca Canada Inc., Mississauga, ON, Canada, 2IMS Brogan Canada, Kirkland, QC, Canada
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Rheumatology 2014 English , Database Study
 
 
Cost of a pulmonary arterial hypertension-related hospitalization in Belgium
Authors: Chevalier P1, De Beule J2, Lamotte M1, Hunsche E2, Regulier E2
Affiliations: 1IMS Health, Vilvoorde,Belgium, 2Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Belgium
Condition Year Language Analysis type
, Rheumatology 2014 English , Cost analysis
 
 
Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study.
Authors: Ogdie A, Yu Y, Haynes K, Love TJ, Maliha S, Jiang Y, Troxel AB, Hennessy S, Kimmel SE, Margolis DJ, Choi H, Mehta NN & Gelfand JM
Affiliations: University of Pennsylvania Division of Rheumatology
Publications: 
Ann Rheum Dis. 2015 Feb;74(2):326-32. doi: 10.1136/annrheumdis-2014-205675. Epub 2014 Oct 28
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25351522
Condition Year Language Analysis type
, Cardiovascular disease, Rheumatology 2014 English , Retrospective database analysis
 
 
Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network.
Authors: Ogdie A, Alehashemi S, Love TJ, Jiang Y, Haynes K, Hennessy S, Choi H & Gelfand JM
Affiliations: University of Pennsylvania Perelman School of Medicine
Publications: 
Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):918-22. doi: 10.1002/pds.3677. Epub 2014 Jul 5.
Document Types: , Article, Poster
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25044030
Condition Year Language Analysis type
, Orthopedics, Rheumatology 2014 English , Retrospective database analysis
 
 
Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study.
Authors: Rho YH, Lu N, Peloquin CE, Man A, Zhu Y, Zhang Y & Choi HK
Affiliations: Boston University School of Medicine The Clinical Epidemiology Unit
Publications: 
2016;75:91-95
Ann Rheum Dis doi:10.1136/annrheumdis-2014-205827
Document Types: , Article
Countries: , UK
Abstract: http://ard.bmj.com/content/early/2014/09/02/annrheumdis-2014-205827.abstract
Condition Year Language Analysis type
, Diabetes, Rheumatology 2014 English , Retrospective database analysis
 
 
Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study
Authors: Dubreuil M, Rho YH, Man A, Zhu Y, Zhang Y, Love TJ, Ogdie A, Gelfand JM & Choi HK
Affiliations: Boston University School of Medicine Section of Rheumatology and the Clinical Epidemiology Unit
Publications: 
Rheumatology (Oxford). 2014 Feb;53(2):346-52. doi: 10.1093/rheumatology/ket343. Epub 2013 Oct 31.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894671/
Condition Year Language Analysis type
, Diabetes, Rheumatology 2014 English , Retrospective database analysis
 
 
Comorbidities in rotator cuff disease: a case-control study
Authors: Titchener AG, White JJ, Hinchliffe SR, Tambe AA, Hubbard RB & Clark D
Affiliations: Royal Derby Hospital Department of Trauma and Orthopaedics
Publications: 
J Shoulder Elbow Surg. 2014 Sep;23(9):1282-8. doi: 10.1016/j.jse.2013.12.019. Epub 2014 Mar 4
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24618192
Condition Year Language Analysis type
, Musculoskeletal disease, Rheumatology 2014 English , Retrospective database analysis
 
 
Annual Cost of Patients with Osteoarthritis of the Hip and Knee in France
Authors: Bertin P1, Rannou F2, Grange L3, Dachicourt JN4, Bruel P5, Emery C6, Grandfils N7, Taieb C8
Affiliations: 1Service de Rhumatologie, C.H.U. Dupuytren, Limoges, France, 2Service de Rééducation, Pôle Ostéo-Articulaire, C.H.U Cochin, Paris, France, 3Clinique universitaire de Rhumatologie, Pôle Locomotion Rééducation et Physiologie CHU de Grenoble/ Hôpital Sud, Echirolles, France, 4Association Française de Lutte Anti-Rhumatismale, Paris, France, 5Département Médical, Pierre Fabre Santé, Castres, France, 6CEMKA-EVAL, Pôle Biostatistiques, Bourg-La-Reine, France, 7IMS Health,Puteaux, France, and 8Public Health, PFSA, Paris, France
Publications: 
Journal of Musculoskeletal pain, Early Online : 1-9, 2014
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Rheumatology 2014 English
 
 
Coût du Lupus Systémique (LS) en France des patients adultes avec une maladie active et traitée (étude LUCIE)
Authors: Amoura Z1, Deligny C2, Pennaforte JL3, Hamidou M4, Blanco P5, Hachulla E6, Pourrat J7, Queyrel V8, Garofano A9, Maurel F9, Levy-Bachelot L10, Boucot I10.
Affiliations: 1Service de médecine interne 2, Centre national de référence lupus, hôpital La Pitié-Salpétrière, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France. 2Service de médecine interne et rhumatologie, CHU de Fort-de-France, BP 63297261, Fort-de-France cedex, Martinique. 3Service de médecine interne, hôpital Robert-Debré, rue du Général-Koenig, 51090 Reims, France. 4Service de médecine interne, hôpital Hôtel-Dieu, place Alexis-Ricordeau, 44093 Nantes cedex 1, France. 5Service de médecine interne, hôpital Pèllegrin, place Amélie-Rabat-léon, 33076 Bordeaux cedex, France. 6Service de médecine interne, hôpital Huriez, 1, place de Verdun, 59037 Lille cedex, France. 7Service de néphrologie et immunologie clinique, hôpital Rangueil, 1, avenue du Professeur-Jean-Pouhlès TSA 50032, 31059 Toulouse cedex 9, France. 8Service de médecine interne, hôpital l'Archet, 151, route Saint-Antoine-Ginestière BP 79, 06202 Nice cedex 3, France. 9IMS Real-World Evidence Solutions, Health Economics & Outcomes Research, Tour Ariane, 5-7, place de la Pyramide, 92088 La Défense cedex, France. 10GlaxoSmithKline, 100, route de Versailles, 78163 Marly-le-Roi cedex, France.
Publications: 
Rev Med Interne. 2014 Nov;35(11):700-8
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Immunology and Vaccination, Nephrology, Rheumatology 2014 French , Cost of illness, Observational study, Retrospective Field Study
 
 
Annual direct medical cost of active systemic lupus erythematosus in five European countries.
Authors: Doria A1, Amoura Z, Cervera R, Khamastha MA, Schneider M, Richter J, Guillemin F, Kobelt G, Maurel F, Garofano A, Perna A, Murray M, Schmitt C, Boucot I.
Affiliations: 1Division of Rheumatology, University of Padova, , Padova, Italy.
Publications: 
Ann Rheum Dis. 2014 Jan;73(1):154-60
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Immunology and Vaccination, Nephrology, Rheumatology 2014 English , Observational study
 
 
Annual Cost of Patients with Osteoarthritis of the Hip and Knee in France
Authors: Bertin P1, Rannou F2, Grange L3, Dachicourt JN4, Bruel P5, Emery C6, Grandfils N7, Taieb C8
Affiliations: 1Service de Rhumatologie, C.H.U. Dupuytren, Limoges, France, 2Service de Rééducation, Pôle Ostéo-Articulaire, C.H.U Cochin, Paris, France, 3Clinique universitaire de Rhumatologie, Pôle Locomotion Rééducation et Physiologie CHU de Grenoble/ Hôpital Sud, Echirolles, France, 4Association Française de Lutte Anti-Rhumatismale, Paris, France, 5Département Médical, Pierre Fabre Santé, Castres, France, 6CEMKA-EVAL, Pôle Biostatistiques, Bourg-La-Reine, France, 7IMS Health,Puteaux, France, and 8Public Health, PFSA, Paris, France
Publications: 
Journal Of Musculoskeletal Pain, Early Online: 1–9, 2014
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Rheumatology 2014 English , Retrospective database analysis
 
 
Understanding Treatment Patterns of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Proton Pump Inhibitors (PPIs) in Patients with the Signs and Symptoms of Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS)
Authors: Dziarmaga A1, Reide Kl2, White R1, Tarride J1, Corner N2
Affiliations: 1 A straZeneca 2 IMS Brogan Canada (A Unit of IMS Health)
Publications: 
ISPOR 2014
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/nsaids-ispor-banner-2014-print.pdf
Condition Year Language Analysis type
, Rheumatology 2014 English , Longitudinal study
 
 
Estimating the annual medical costs for newly treated dupuytren’s contracture patients in the real world.
Authors: Kowal S, Ferrufino C, Munakata J, Tursi J
Affiliations: 
Publications: 
Academy of Managed Care Pharmacy (AMCP) 26th annual Meeting & Expo, 2014 April, Tampa, FL
Document Types: 
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2014 English , Cost analysis
 
 
Cost per treated patient for biologics for rheumatoid arthritis (RA) using US claims data.
Authors: Schabert VF1, Korn JR1, Bilir SP1, DeKoven M1, Harrison DJ2, Joseph G2
Affiliations: 1 IMS Health, Alexandria, USA, 2 Amgen Inc, Thousand Oaks, USA
Publications: 
European League Against Rheumatism 2013 Congress, Madrid, Spain
Document Types: , Poster
Countries: , Spain, USA
Condition Year Language Analysis type
, Rheumatology 2013 English , Cost analysis
 
 
Algorithm-based estimation of biologic effectiveness for rheumatoid arthritis
Authors: Yun H1, Schabert VF2, Yeaw J2, Korn JR3, Quach C4, Harrison DJ5, Joseph G5, Collier D5
Affiliations: 1 University of Alabama at Birmingham, Birmingham, USA 2 IMS Health, Alexandria, USA 3 IMS Health, Waltham, USA 4 University of North Carolina at Chapel Hill, Chapel Hill, USA 5 Amgen Inc, Thousand Oaks, USA
Publications: 
International Society for Pharmacoeconomics and Outcomes Research 18th International Meeting, New Orleans, LA
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2013 English , Cost effectiveness
 
 
Effectiveness of second line biologic use in rheumatoid arthritis after switching from first-line biologics
Authors: Schabert VF1, Yeaw J1, Korn J2, Quach C3, Harrison DJ4, Yun H5, Joseph G4, Collier D4, Curtis J5
Affiliations: 1 IMS Health, Alexandria, VA, USA, 2 IMS Health, Waltham, MA, USA, 3 University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, 4 Amgen Inc, Thousand Oaks, CA, USA, 5 University of Alabama, at Birmingham, Birmingham, AL, USA
Publications: 
International Society for Pharmacoeconomics and Outcomes Research 18th International Meeting, New Orleans, LA
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2013 English , Review
 
 
Cost per treated patient for biologics across adult indications using claims data
Authors: Schabert VF1, Yeaw J1, Korn J2, Quach C3, Harrison DJ4, Yun H5, Joseph G4, Collier D4, Curtis J5
Affiliations: 1 IMS Health, Alexandria, VA, USA, 2 IMS Health, Waltham, MA, USA, 3 University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, 4 Amgen Inc, Thousand Oaks, CA, USA, 5 University of Alabama, at Birmingham, Birmingham, AL, USA
Publications: 
International Society for Pharmacoeconomics and Outcomes Research 18th International Meeting, New Orleans, LA
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2013 English , Cost analysis
 
 
Using a validated, claims data based algorithm to evaluate the effectiveness of self-injected vs. infused biologics for rheumatoid arthritis claims data
Authors: Schabert VF1, Yeaw J1, Korn J2, Quach C3, Harrison DJ4, Yun H5, Joseph G4, Collier D4, Curtis J5
Affiliations: 
Publications: 
Academy of Managed Care Pharmacy 25th Annual Meeting, San Diego, CA
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2013 English , Observational study
 
 
Costs of tumor necrosis factor blockers per treated patient with psoriatic disease using real-world drug utilization data in a U.S. managed care population
Authors: Schabert VF, Watson C, Burudpakdee C, Joseph G, Iverson P, Harrison DJ
Affiliations: 
Publications: 
71st American Academy of Dermatology Annual Meeting, Miami Beach, FL
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2013 English , Cost analysis
 
 
Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claims.
Authors: Curtis JR1, Schabert VF2, Harrison DJ3, Yeaw J2, Korn JR2, Quach C4, Yun H5, Joseph GJ3, Collier DH6.
Affiliations: 1Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama; Department of Epidemiology, University of Alabama, Birmingham, Alabama. Electronic address: jcurtis@uab.edu. 2IMS Health, Alexandria, Virginia. 3Global Health Economics, Amgen Inc, Thousand Oaks, California. 4Health Policy and Management, University of North Carolina, Chapel Hill, North Carolina. 5Department of Epidemiology, University of Alabama, Birmingham, Alabama. 6Inflammation/Development, Amgen Inc, Thousand Oaks, California.
Publications: 
Clin Ther. 2014 Jul 1;36(7):996-1004.
Document Types: 
Countries: , Spain, USA
Condition Year Language Analysis type
, Rheumatology 2013 English , Cost effectiveness
 
 
A review of cost-effectiveness evaluations as part of national health technology assessments of biologic DMARDs in the treatment of rheumatoid arthritis.
Authors: Sergio Iannazzo 4, Maria De Francesco 1, David Gomez-Ulloa 2 & Maurizio Benucci 3
Affiliations: 1 IMS RWE Solutions & HEOR, Milan, Italy 2 IMS RWE Solutions & HEOR, Barcelona, Spain 3 Rheumatology Unit, Hospital S Giovanni di Dio, Florence Italy 4 IMS RWE Solutions & HEOR, Milan, Italy.
Publications: 
Expert Rev Pharmacoecon Outcomes Res., 2013, Aug, 13(4): 455-468
Document Types: , Article
Countries: , Italy
Condition Year Language Analysis type
, Rheumatology 2013 English , Review
 
 
Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study.
Authors: Trifirò G1, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, Bianchini E, Medea G, Cricelli C, Caputi AP, Mazzaglia G
Affiliations: 1Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Via Consolare Valeria Gazzi, 98125 Messina, Italy.
Publications: 
Ann Rheum Dis. 2013 May;72(5):694-700. doi: 10.1136/annrheumdis-2011-201254. Epub 2012 Jun 26.
Document Types: , Article
Countries: , Italy
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22736095
Condition Year Language Analysis type
, Rheumatology 2013 English , Epidemiological study, Retrospective database analysis
 
 
Prevalence and treatment patterns of psoriatic arthritis in the UK.
Authors: Ogdie A, Langan S, Love T, Haynes K, Shin D, Seminara N, Mehta NN, Troxel A, Choi H & Gelfand JM
Affiliations: University of Pennsylvania Division of Rheumatology
Publications: 
Rheumatology (Oxford). 2013 Mar;52(3):568-75. doi: 10.1093/rheumatology/kes324. Epub 2012 Dec 7.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23221331
Condition Year Language Analysis type
, Dermatology, Orthopedics, Rheumatology 2013 English , Retrospective database analysis
 
 
The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study.
Authors: Choi H K, Rho Y H, Zhu Y, Soriano L C, Avina-Zubieta A & Zhang Y.
Affiliations: 
Publications: 
Ann Rheum Dis. 2013 Jul;72(7):1182-7. doi: 10.1136/annrheumdis-2012-201669. Epub 2012 Aug 28.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22930596
Condition Year Language Analysis type
, Respiratory disease, Rheumatology, Vascular disease 2013 English
 
 
The Use of Biologic Drugs for the Treatment of Rheumatoid Arthritis in Italy.
Authors: Heiman F, Katz P, Pegoraro V, Di Virgilio R
Affiliations: Cegedim Italy
Publications: 
16th Annual European ISPOR Congress Dublin, Ireland
Document Types: , Poster
Countries: , Italy
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)03365-2/abstract
Condition Year Language Analysis type
, Rheumatology 2013 English , Retrospective database analysis
 
 
Impact de la baisse du taux de remboursement des anti-arthrosiques symptomatiques d’action lente (AASALs) sur la prescription des AINS par les médecins généralistes français
Authors: P Hilliquin (1); S Bouée (2); I Dardour (3); A Letierce (4); V Leblanc (3); - (1) Corbeil-Essonnes - France; (2) Bourg-la-Reine - France; (3) Courbevoie - France; (4) Boulogne-Billancourt - France
Affiliations: 
Publications: 
26ème congrès français de Rhumatologie
Document Types: , Poster
Countries: , France
Abstract: http://poster.rhumatologie.asso.fr/
Condition Year Language Analysis type
, Pain, Pricing and reimbursement, Rheumatology 2013 French , Retrospective database analysis
 
 
Design of Lupus Impact Tracker (LIT) Validation Study in Five European Clinical Practice Settings
Authors: M. Schneider, M. Mosca, J.M. Pego-Reigosa, V. Koscielny, L. Moore-Ramdin, H. Devilliers
Affiliations: 1Heine-University Heinrich Düsseldorf, Düsseldorf, Allemagne ; 2Université de Pise, Pise, Italie ; 3Hospital faire Meixoeiro, Vigo, en Espagne ; 4GlaxoSmithKline, Londres, Angleterre ; 5CHU de Dijon, Dijon, France.
Publications: 
ISPOR 16th 02/06 Novembre 2013 Dublin
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Immunology and Vaccination, Nephrology, Rheumatology 2013 English
 
 
Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study
Authors: Schabert VF, Bruce B, Ferrufino CF, Globe DR, Harrison DJ, Lingala B, Fries JF
Affiliations: 1,3 IMS Health, Falls Church, VA. 2,6-7 Stanford University School of Medicine. 4-5 Amgen
Publications: 
Curr Med Res Opin
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2012 English , Observational study
 
 
Annual costs of tumor necrosis factor inhibitors using real-world data in a commercially insured population in the United States
Authors: Schabert VF, Watson C, Gandra SR, Goodman S, Fox KM, Harrison DJ
Affiliations: 1,4 IMS Health, Falls Church, VA, US, 2-3,6 Amgen, 5 Strategic Healthcare Solutions
Publications: 
J Med Econ
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2012 English , Budget impact
 
 
Frequency of administration of biologics has an impact on treatment decision making.
Authors: Chevalier P1, Black C2,3, Lamotte M1, Crombach J4, Huismans J4, Rosiek R5, Fan T3
Affiliations: 1 IMS HEOR, Vilvoorde, Belgium 2 St. John’s University 3 Merck & Co. 4 MSD, Netherlands 5 Medithuis B.V.
Publications: 
15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany
Document Types: , Abstract, Poster
Countries: , Netherlands
Condition Year Language Analysis type
, Rheumatology 2012 English , Retrospective database analysis
 
 
Obesity and the risk of psoriatic arthritis: a population-based study.
Authors: Love TJ, Zhu Y, Zhang Y, Wall-Burns L, Ogdie A, Gelfand JM, Choi HK.
Affiliations: Landspitali University Hospital Department of Science, Education, and Innovation
Publications: 
Ann Rheum Dis. 2012 Aug;71(8):1273-7. doi: 10.1136/annrheumdis-2012-201299. Epub 2012 May 14.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22586165
Condition Year Language Analysis type
, Obesity, Orthopedics, Rheumatology 2012 English , Retrospective database analysis
 
 
Risk factors for pseudogout in the general population.
Authors: Rho YH, Zhu Y, Zhang Y, Reginato AM & Choi HK.
Affiliations: Boston University School of Medicine Section of Rheumatology and the Clinical Epidemiology Unit
Publications: 
Rheumatology (Oxford). 2012 Nov;51(11):2070-4. doi: 10.1093/rheumatology/kes204. Epub 2012 Aug 11.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22886340
Condition Year Language Analysis type
, Orthopedics, Rheumatology 2012 English , Retrospective database analysis
 
 
Therapy switching, augmentation, and discontinuation in patients with osteoarthritis and chronic low back pain.
Authors: Gore M, Sadosky AB, Leslie DL, Tai KS & Emery P.
Affiliations: Avalon Health Solutions, Inc.
Publications: 
Pain Pract. 2012 Jul;12(6):457-68. doi: 10.1111/j.1533-2500.2011.00524.x. Epub 2012 Jan 9.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22230466
Condition Year Language Analysis type
, Orthopedics, Rheumatology 2012 English , Retrospective database analysis
 
 
Estimating the Impact of Adherence to Allopurinol Therapy on Cardiovascular Outcomes in Gout Patients Using the Health Improvement Network (THIN) General Practice Database.
Authors: Rabi R, Elliott R & Quinn C
Affiliations: 
Publications: 
Society for Academic Primary Care (SAPC), SAPC Bristol 6-8 July 2011
Document Types: , Conference
Countries: , UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(11)02385-0/abstract
Condition Year Language Analysis type
, Rheumatology 2012 English
 
 
Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care.
Authors: Lapi F1, Simonetti M, Michieli R, Pasqua A, Brandi ML, Frediani B, Cricelli C, Mazzaglia G.
Affiliations: 1Department of Preclinical and Clinical Pharmacology, University of Florence, Italy
Publications: 
Bone. 2012 Jan;50(1):85-90. doi: 10.1016/j.bone.2011.09.048. Epub 2011 Oct 2.
Document Types: , Article
Countries: , Italy
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21985999
Condition Year Language Analysis type
, Orthopedics, Rheumatology 2012 English , Retrospective database analysis
 
 
Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study
Authors: Trifirò G1, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, Bianchini E, Medea G, Cricelli C, Caputi AP, Mazzaglia G
Affiliations: 1Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Via Consolare Valeria Gazzi, 98125 Messina, Italy
Publications: 
Ann Rheum Dis. 2013 May;72(5):694-700
Document Types: , Abstract
Countries: , Italy
Condition Year Language Analysis type
, Rheumatology 2012 French , Epidemiological study, Retrospective database analysis
 
 
Baseline characteristics and pre–index total health care and rheumatoid arthritis-related costs in patients receiving Golimumab therapy
Authors: Carter C1, Tandon N1, Smith D2
Affiliations: 1Centocor Ortho Biotech Services, LLC, Horsham, PA, USA, 2IMS Health Incorporated, Watertown, MA, USA
Publications: 
ISPOR 16th Annual International Meeting, May 21-25 2011, Baltimore, USA
Document Types: , Poster
Countries: , USA
Abstract: http://www.ispor.org/meetings/baltimore0511/Posters1.aspx
Condition Year Language Analysis type
, Rheumatology 2011 English , Cost of illness
 
 
Biologic experience and dosing of Golimumab patients in managed care
Authors: Carter C1, Tandon N1, Smith D2
Affiliations: 1Centocor Ortho Biotech Services, LLC, Horsham, PA, USA, 2IMS Health Incorporated, Watertown, MA, USA
Publications: 
ISPOR 16th Annual International Meeting, May 21-25 2011, Baltimore, USA
Document Types: , Poster
Countries: , USA
Abstract: http://www.ispor.org/meetings/baltimore0511/Posters1.aspx
Condition Year Language Analysis type
, Rheumatology 2011 English , Observational study
 
 
Explanatory factors for the Rheumatoid Arthritis patients' access to biological agents in 15 European countries
Authors: Laires PA1, Exposto F2, Barosa P2, Hormigos B2, Martins AP1
Affiliations: 1Merck, Sharp & Dohme, Oeiras, Portugal, 2IMS Health, Oeiras, Portugal
Publications: 
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: 
Abstract: http://www.ispor.org/congresses/Spain1111/Posters1.aspx
Condition Year Language Analysis type
, Rheumatology 2011 English , Cost effectiveness
 
 
Costs of tumor necrosis factor blockers per treated patient across adult indications using real-world data in US commercially-insured population.
Authors: Schabert V1, Gandra SR2, Watson C2, Fox KM3, Yeaw J4, Goodman S4, Milev S5, Harrison DJ2.
Affiliations: 1IMS Health, Falls Church, VA, USA, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4IMS Health, Watertown, MA, USA, 5IMS Brogan, A unit of IMS, Ottawa, ON, Canada
Publications: 
14th Annual European Congress, International Society of Pharmacoeconomics and Outcomes Research (ISPOR)
Document Types: , Poster
Countries: , Spain
Abstract: http://www.ispor.org/congresses/Spain1111/Posters1.aspx
Condition Year Language Analysis type
, Rheumatology 2011 English , Budget impact
 
 
Costs of tumor necrosis factor blockers per treated rheumatoid arthritis patient using real-world drug data in US commercially-insured population.
Authors: Schabert VF, Gandra S, Watson C, Yeaw J, Goodman S, Fox KM, Milev S, Harrison DJ.
Affiliations: 
Publications: 
ACR/ARHP Annual Scientific Meeting
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2011 English
 
 
Etanercept treatment for psoriatic disease.
Authors: Schabert VF1, Harrison DJ2, Globe DR2, Goodman S1, Burudpakdee C1.
Affiliations: 1 IMS Health, Falls Church, VA, US 2 2 Amgen, Thousand Oaks, CA, USA
Publications: 
Am J Pharm Benefits. 2011;3(3):e51-e58
Document Types: , Manuscript in preparation
Countries: 
Condition Year Language Analysis type
, Rheumatology 2011 English , Budget impact
 
 
Patient characteristics, biologic experience, and real-world dosing of golimumab.
Authors: Carter CT1, Tandon N1, Smith DB2
Affiliations: 1Centocor Ortho Biotech Inc., Horsham, PA, USA, 2IMS Consulting Group, Watertown, MA, USA
Publications: 
The European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology, London, UK, May 25-28, 2011.
Document Types: , Abstract
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2011 English , Retrospective database analysis
 
 
Biologic experience and systemic medication use among commercially insured psoriasis patients receiving ustekinumab.
Authors: Carter CT1, Martin S1, Denny L1, Smith D2
Affiliations: 1Janssen Scientific Affairs, LLC., Horsham, PA, USA, 2IMS Consulting Group, Watertown, MA, USA
Publications: 
Society for Medical Decision Making (SMDM), October 23-26, 2011, Chicago, IL, USA
Document Types: , Abstract, Poster
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2011 English , Retrospective database analysis
 
 
Frequency and risk factors of gout flares in a large population-based cohort of incident gout.
Authors: Rothenbacher D, Primatesta P, Ferreira A, Cea-Soriano L, Rodríguez LA.
Affiliations: 
Publications: 
Rheumatology (Oxford). 2011 May;50(5):973-81. doi: 10.1093/rheumatology/keq363. Epub 2011 Jan 12.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21228059
Condition Year Language Analysis type
, Rheumatology 2011 English
 
 
Prevalence of long-term oral glucocorticoid prescriptions in UK over the past 20 years.
Authors: Fardet L, Petersen I, Nazareth I.
Affiliations: UCL MRC General Practice Research Framework
Publications: 
Rheumatology (Oxford). 2011 Nov;50(11):1982-90. doi: 10.1093/rheumatology/ker017. Epub 2011 Mar 10.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21393338
Condition Year Language Analysis type
, Musculoskeletal disease, Rheumatology 2011 English , Epidemiological study, Retrospective database analysis
 
 
Management of osteoporosis and associated quality of life in post menopausal women.
Authors: Cortet B1, Blotman F, Debiais F, Huas D, Mercier F, Rousseaux C, Berger V, Gaudin AF, Cotté FE.
Affiliations: 1Laboratoire GlaxoSmithKline, Marly-le-Roi, France.
Publications: 
BMC Musculoskelet Disord. 2011; 12: 7.
Document Types: , Article
Countries: , France
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034724/
Condition Year Language Analysis type
, Orthopedics, Rheumatology, Womens Health 2011 English , Prospective study
 
 
Impact of diabetes against the future risk of developing gout
Authors: Rodríguez LA, Soriano LC & Choi HK
Affiliations: Spanish Centre for Pharmacoepidemiological Research (CEIFE), Madrid, Spain
Publications: 
Ann Rheum Dis. 2010 Dec;69(12):2090-4. doi: 10.1136/ard.2010.130013. Epub 2010 Jun 22.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136217/
Condition Year Language Analysis type
, Diabetes, Rheumatology 2010 English , Retrospective database analysis
 
 
The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK
Authors: Cooper C, Steinbuch M, Stevenson R, Miday R & Watts NB
Affiliations: Rheumatology, University of Southampton
Publications: 
Osteoporos Int. 2010 Apr;21(4):569-77. doi: 10.1007/s00198-009-1003-1. Epub 2009 Jun 23.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19547906
Condition Year Language Analysis type
, Orthopedics, Rheumatology 2010 English , Retrospective database analysis
 
 
Risk of upper gastrointestinal tract events in risedronate users switched to alendronate.
Authors: Ralston SH, Kou TD, Wick-Urban B, Steinbuch M & Masud T
Affiliations: Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh
Publications: 
Calcif Tissue Int. 2010 Oct;87(4):298-304. doi: 10.1007/s00223-010-9401-0. Epub 2010 Aug 29.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20803291
Condition Year Language Analysis type
, Gastrointestinal disorders, Rheumatology 2010 English , Retrospective database analysis
 
 
Frequency and Risk Factors of Gout Flares in a Large Population-Based Cohort of Incident Gout
Authors: Rothenbacher D, Primatesta P, Ferreira A, Soriano L & Garcia Rodriguez L
Affiliations: Global Clinical Epidemiology, Novartis Pharma AG, Basel, Switzerland
Publications: 
Pharmacoepidemiology and Drug Safety (19): S1-S347
Document Types: , Abstract
Countries: , UK
Condition Year Language Analysis type
, Rheumatology 2010 English , Retrospective database analysis
 
 
Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women.
Authors: Breuil V1, Cortet B, Cotté FE, Arnould B, Dias-Barbosa C, Gaudin AF, Regnault A, Roborel de Climens A, Legrand E.
Affiliations: 1Rheumatology Department, Nice University Hospital, Nice, France.
Publications: 
Osteoporos Int. 2012 Feb;23(2):445-55
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Rheumatology, Womens Health 2010 English , Prospective study, Quality of life, Retrospective database analysis
 
 
Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment.
Authors: Huas D1, Debiais F, Blotman F, Cortet B, Mercier F, Rousseaux C, Berger V, Gaudin AF, Cotté FE.
Affiliations: Department of General Practice, UFR Paris 7, Paris, France.
Publications: 
BMC Womens Health. 2010 Aug 20;10:26
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Rheumatology, Womens Health 2010 English , Prospective study
 
 
Differences in annual medication costs and dosage-increase rates between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population.
Authors: Ollendorf DA1, Klingman D2, Hazard E, Ray S3
Affiliations: 1 IMS Health, Inc., Norwalk, CT, USA 2 IMS Health, Inc., Falls Church, VA, USA 3 Abbott Laboratories, Abbott Park, IL, USA
Publications: 
Clinical Therapeutics, 2009, 31(4): 825-835
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Rheumatology 2009 English , Retrospective database analysis
 
 
Percepción de los médicos de Atención Primaria en el manejo clínico de la osteoporosis. Influencia de los Planes de Salud. [Primary care perception of clinical management of osteoporosis. The influence of healthcare policies]
Authors: Carbonell Abella C, Abizanda González M, Pérez Hernández M, Roset Gamisans M, Nogués Solán X
Affiliations: Carbonell Abella C1, Abizanda González M2, Pérez Hernández M3, Roset Gamisans M4, Nogués Solán X5 1 Centro de Salud Vía Roma. Barcelona. Facultad de Medicina. Universidad de Barcelona. España. 2 Centro de Atención Primaria Vila Olímpica. Barcelona. España. 3 Laboratorios Almirall. Barcelona. España. 4 IMS Health. Barcelona. España. 5 eUnidad de Investigación de Fisiopatología Ósea y Articular del Institut Municipal d'Investigacions Mèdiques (IMIM). Departamento de Medicina Interna. Universidad Autónoma de Barcelona. Hospital del Mar. Barcelona.
Publications: 
Semergen 2009;35(3)122-30
Document Types: , Article
Countries: , Spain
Abstract: http://www.elsevier.es/revistas/ctl_servlet?_f=7012&articuloid=13135236&revistaid=40
Condition Year Language Analysis type
, Rheumatology 2009 Spanish , Survey research
 
 
Indirect costs of rheumatoid arthritis and their determinants
Authors: Maurel F1, Bardoulat I1, Camara C2, Schadtler Law L3, Le Pen C4
Affiliations: 1 IMS Health, Puteaux, France, 2 Wyeth Pharmaceuticals France, Paris La Défense , France, 3 Wyeth Pharmaceuticals France, Paris La Défense Cedex, France, 4 Dauphine University, Paris, France
Publications: 
EULAR 2009
ISPOR 12th Annual European Congress, Paris, France 24-27 October 2009
Document Types: , Poster
Countries: , France
Abstract: http://www.ispor.org/congresses/paris1009/Posters3.aspx
Condition Year Language Analysis type
, Rheumatology 2009 English , Economic evaluation
 
 
Impact of Rheumatoid Arthritis (RA) on working conditions and income
Authors: Maurel F1, Fautrel B2, Maravic M3, Bardoulat I1, Preiss P4, Camara C5, Schadtler Law L6, Le Pen C7
Affiliations: 1 IMS Health, Puteaux, France 2 Groupe Hospitalier Pitié-Salpêtrière, Paris, France, 3 Hopital Leopold Bellan, Paris, France, 4 Association Française des Polyarthritiques, Paris, France, 5 Wyeth Pharmaceuticals France, Paris La Défense, France, 6 Wyeth Pharmaceuticals France, Paris La Défense Cedex, France, 7 Dauphine University, Paris, France
Publications: 
ISPOR 12th Annual European Congress, Paris, France, 24-27th October 2009
Document Types: , Poster
Countries: , France
Abstract: http://www.ispor.org/congresses/paris1009/Posters3.aspx
Condition Year Language Analysis type
, Rheumatology 2009 English , Burden of illness
 
 
Healthcare costs for rheumatoid arthritis patients treated with abatacept, infliximab, or rituximab.
Authors: Trivedi DN1, Chapman RH2, Smith D1, Semroc G2, Rosenblatt LC1
Affiliations: 1 Bristol-Myers Squibb, Plainsboro, NJ, USA 2 IMS Health, Inc., Falls Church, VA, USA
Publications: 
Academy of Managed Care Pharmacy's 21st Annual Meeting, 2009, April 15-18, Orlando, FL, USA
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Rheumatology 2009 English , Retrospective cohort analysis
 
 
Dosing patterns for rheumatoid arthritis patients treated with abatacept or infliximab.
Authors: Trivedi DN1, Chapman RH2, Smith D2, Semroc G2, Rosenblatt LC1
Affiliations: 1 Bristol-Myers Squibb, Princeton, NJ, USA 2 IMS Health, Inc., Falls Church, VA, USA
Publications: 
Value in Health, 2009, 12(3): A65
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Rheumatology 2009 English , Retrospective cohort analysis
 
 
Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population.
Authors: Ollendorf DA, Klingman D, Hazard E, Ray S.
Affiliations: IMS Health, Inc., Norwalk, Connecticut, USA. dollendorf@icer-review.org
Publications: 
Clin Ther. 2009 Apr;31(4):825-35.
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Rheumatology 2009 English , Retrospective database analysis
 
 
Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA.
Authors: Joyce AT, Smith P, Khandker R, Melin JM, Singh A.
Affiliations: PharMetrics, Inc., 311 Arsenal Street, Watertown, MA 02472, USA. ajoyce@us.imshealth.com
Publications: 
J Rheumatol. 2009 Apr;36(4):743-52. Epub 2009 Feb 17.
Document Types: , Article
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2009 English , Retrospective database analysis
 
 
Healthcare costs for rheumatoid arthritis patients treated with abatacept, infliximab, or rituximab.
Authors: Chapman RH1, Smith D, Semroc G1, Trivedi DN, Rosenblatt LR.
Affiliations: 2 IMS Health, Falls Church, VA, USA 4 IMS Health, Falls Church, VA, USA
Publications: 
2008 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting,
Academy of Managed Care Pharmacy’s 21st Annual Meeting, 2009, April 15-18, Orlando, FL, USA
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2008 English , Retrospective cohort analysis
 
 
Expectativas, preferencias y satisfacción de los pacientes con artritis reumatoide en tratamiento con infliximab. [Expectations, preferences and satisfaction of patients with rheumatoid arthritis receiving infliximab treatment]
Authors: Carbonell J1, Badia X2, EXPRESAR GROUP
Affiliations: 1Servicio de Reumatología. Hospital del Mar. Barcelona. 2Health Economics & Outcomes Research. IMS Health. Barcelona. España.
Publications: 
Med Clin (Barc) 2008;131(13):493-9.
Document Types: , Article
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19007577
Condition Year Language Analysis type
, Rheumatology 2008 Spanish , Quality of life
 
 
Using HAQ to estimate HUI3 and EQ-5D utility values in Spanish rheumatoid arthritis patients
Authors: Fernández I, Varela C, Layola M, Ruiz MD, Navarro F
Affiliations: 
Publications: 
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Rheumatology 2008 English , Quality of life
 
 
European study of health related quality-of-life in patients with gout.
Authors: Van Vlaenderen I1, Strens D1, Annemans L, Murdock SC
Affiliations: 1 IMS Health, Brussels, Belgium
Publications: 
Ann Rheum Dis., 2008, 67(Suppl II): 580
Document Types: , Article
Countries: , Europe
Condition Year Language Analysis type
, Rheumatology 2008 English , Quality of life
 
 
Patterns of rituximab use among patients in a managed care setting: results from a U.S. claims data analysis.
Authors: Pelletier EM1, Yu E2
Affiliations: 1IMS Health, Watertown, MA, USA, 2Genetech Inc., South San Francisco, CA, USA
Publications: 
Academy of Managed Care Pharmacy (AMCP) Educational Conference, 2008, October 15-18, Kansas City, MO, USA
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2008 English , Retrospective database analysis
 
 
The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study.
Authors: Poole CD, Conway P, Reynolds A & Currie CJ
Affiliations: 360o Research Limited, Penarth
Publications: 
BMC Musculoskelet Disord. 2008 Nov 4;9:146. doi: 10.1186/1471-2474-9-146.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18983663
Condition Year Language Analysis type
, Rheumatology 2008 English , Retrospective database analysis
 
 
Hidden cost of rheumatoid arthritis: estimating cost of comorbid cardiovascular disease and depression among rheumatoid arthritis patients
Authors: Joyce AT, Khandker RK, Smith PJ, Singh A
Affiliations: 
Publications: 
ISPOR 2007 10th Annual European Congress
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Rheumatology 2007 English , Cost of illness
 
 
A microsimulation-based cost-utility analysis of Rituximab (Mabthera®) in patients with rheumatic arthritis in Spain
Authors: Fernández I, Varela C, Badia X, Carreño Á, Polanco C
Affiliations: 
Publications: 
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Rheumatology 2007 English , Cost utility
 
 
Diagnostic indicators of restless legs syndrome in primary care consultations: the DESYR study.
Authors: Crochard A1, El Hasnaoui A, Pouchain D, Huas D, Arnulf I, Krieger J, Lainey E, Le Jeunne P, Leger D, Schuck S, Texier N, Tison F, Montplaisir J
Affiliations: 1Laboratoire GlaxoSmithKline, Marly-le-Roi, France.
Publications: 
Mov Disord. 2007 Apr 30;22(6):791-7
Document Types: , Abstract
Countries: , France
Condition Year Language Analysis type
, Rheumatology 2007 English , Prospective study, Retrospective database analysis
 
 
Annual treatment costs of patients with rheumatoid arthritis with metotrexate and leflunomide in spain.
Authors: Rebollo P , Prieto L, Garcia A , Betegón L , Echevarria A
Affiliations: 
Publications: 
ISPOR 2007 10th Annual European Congress
Document Types: , Abstract
Countries: , Spain
Condition Year Language Analysis type
, Rheumatology 2006 English , Cost of illness
 
 
Cost-utility analysis of rituximab as a new therapeutic option for rheumatoid arthritis patients in Canada
Authors: Mistry B1, McCormick J2, Diamantopoulos A3, Kielhorn A4
Affiliations: 1 Hoffmann-La Roche Ltd, Mississauga, ON, Canada, 2McKesson Phase 4 Solutions, Toronto, ON, Canada, 3M-TAG UK Ltd, London, UK, 4F. Hoffmann-La Roche Ltd, Basel, Switzerland
Publications: 
ISPOR 9th Annual European Congress. Copenhagen, Denmark
Value in Health, 2006, 9(6): A222
Document Types: , Abstract, Poster
Countries: , Canada
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)63265-2/abstract
Condition Year Language Analysis type
, Rheumatology 2006 English , Cost utility
 
 
Prevalence of Depressive Symptoms in Postmenopausal Women with Low Bone Mineral Density and/or Prevalent Vertebral Fracture: Results from the Multiple Outcomes of Raloxifene Evaluation (MORE) Study.
Authors: Silverman SL, Shen W, Minshall ME, Xie S, and Moses KH.
Affiliations: 
Publications: 
The Journal of Rheumatology, 2007; 34(1):140-144.
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2006 English , Epidemiological study
 
 
Development and validation of a satisfaction with treatment questionnaire in patients with rheumatoid artritis.
Authors: Carbonell J, Badia X and Grupo Expressar.
Affiliations: 
Publications: 
Reumatol Clin 2006;2(3):137-45
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Rheumatology 2006 English , Quality of life
 
 
Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis.
Authors: Suissa S, Hudson M, Ernst P
Affiliations: 
Publications: 
Arthritis Rheum., 2006, 54(5): 1435-9
Document Types: , Article
Countries: , USA
Condition Year Language Analysis type
, Rheumatology 2006 English , Retrospective database analysis
 
 
Do patients with older onset rheumatoid arthritis receive less aggressive treatment than younger patients
Authors: Tutuncu Z, Reed G, Kremer J, Kavanaugh A
Affiliations: 
Publications: 
Ann Rheum Dis 2006; 65(9):1226-1229
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Rheumatology 2006 English , RWLPR (Real-World Late Phase Research-quintiles
 
 
The CORRONA database
Authors: Kremer JM
Affiliations: 
Publications: 
Autoimmun Rev. 2006; 5(1):46-54
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Rheumatology 2006 English , RWLPR (Real-World Late Phase Research-quintiles
 
 
Copyright 2024 IMS Health Incorporated. All rights reserved.